Update on Pfizer COVID-19 Booster Doses

To the Case Western Reserve Community:

We are pleased to announce that eligible faculty, staff and students will be able to receive booster doses of Pfizer’s COVID-19 vaccines starting today (Monday, Sept. 27). 

After extensive review, the Food and Drug Administration (FDA) Wednesday authorized the use of the Pfizer vaccine for use as a booster against COVID-19. The Centers for Disease Control and Prevention director, Rochelle Walensky, Thursday endorsed its advisory committee’s recommendations, and also added a recommendation that those in high-risk and institutional settings also be eligible for the booster. 

Details of the CDC recommendations can be found in this announcement, but fundamentally they break down into two groups: those who should receive a booster, and those who may get one.

Those who should receive a booster are those who received their second Pfizer vaccine dose at least six months ago and are:

  • people 65 and older as well as residents of long-term care settings who received their second Pfizer vaccine dose at least six months ago; and
  • people 50 to 64 years of age who have underlying medical conditions, among them those with cancer, diabetes or heart conditions, as well as individuals who are pregnant or immunocompromised. 

Those who may receive a booster are those who received their second Pfizer vaccine dose at least six months ago and are:

  • people 18 to 49 years of age who have underlying medical conditions, among them those with cancer, diabetes or heart conditions, as well as individuals who are pregnant or immunocompromised; and
  • people 18 to 64 years of age who are at increased risk for COVID-19 exposure and transmission because of the nature of their work or the type of institution where they work or live. The FDA has indicated such groups include health care and child care workers, as well as teachers. Also included would be those in long-term health care facilities, inmates and homeless shelter residents.

Those who received the Moderna or Johnson & Johnson vaccines are not eligible for the Pfizer boosters. Moderna previously submitted its application to the FDA for booster dose approval; last week Johnson & Johnson announced strong results from the final phase of a study of the effectiveness and safety of its booster dose.

To schedule an appointment to receive a Pfizer booster dose, please visit myhealthconnect.case.edu. After entering your date of birth, click on “appointments” in the website's navigation and then follow the prompts. Please bring your vaccination card with you to the vaccination site, which is in the former nursing school building. Please use the entrance immediately east of the Biomedical Research Building (clock tower) on the health sciences podium. Please visit the university’s COVID-19 vaccine website for additional information.

CVSWalgreens and Walmart have all announced nationwide availability for Pfizer booster doses as well. 

We will provide additional vaccine updates as they become available.

Sara Lee, MD
Executive Director, University Health and Counseling Services

Megan Koeth
Executive Director, Office of Resiliency